Chemiesynth (Vapi) Ltd
₹ 35.8
4.98%
14 Oct 2024
About
Chemiesynth (Vapi) is a custom manufacturing for leading Agrochemical, Pharmaceutical and Specialty Chemical Companies.(Source : 201903 Annual Report Page No:28)
Key Points
- Market Cap ₹ 11.0 Cr.
- Current Price ₹ 35.8
- High / Low ₹ 0.00 / 0.00
- Stock P/E
- Book Value ₹ 35.8
- Dividend Yield 0.00 %
- ROCE 2.99 %
- ROE -0.99 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.00 times its book value
- Company's working capital requirements have reduced from 29.3 days to 12.8 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.35% over past five years.
- Company has a low return on equity of 0.18% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
9.63 | 11.13 | 5.12 | 3.09 | 13.32 | 11.20 | 14.56 | 19.90 | 30.18 | 20.94 | 16.43 | 18.89 | |
9.10 | 11.55 | 5.26 | 3.17 | 12.67 | 9.26 | 12.27 | 14.32 | 25.71 | 18.37 | 14.88 | 16.71 | |
Operating Profit | 0.53 | -0.42 | -0.14 | -0.08 | 0.65 | 1.94 | 2.29 | 5.58 | 4.47 | 2.57 | 1.55 | 2.18 |
OPM % | 5.50% | -3.77% | -2.73% | -2.59% | 4.88% | 17.32% | 15.73% | 28.04% | 14.81% | 12.27% | 9.43% | 11.54% |
0.13 | 0.02 | 0.03 | 0.27 | 0.46 | 0.06 | 0.12 | 0.02 | 0.94 | 0.00 | 0.01 | 0.01 | |
Interest | 0.30 | 0.29 | 0.23 | 0.19 | 0.19 | 0.09 | 0.28 | 0.48 | 0.50 | 0.59 | 0.71 | 0.80 |
Depreciation | 0.25 | 0.28 | 0.20 | 0.18 | 0.52 | 0.46 | 0.55 | 0.78 | 1.05 | 1.17 | 1.30 | 1.40 |
Profit before tax | 0.11 | -0.97 | -0.54 | -0.18 | 0.40 | 1.45 | 1.58 | 4.34 | 3.86 | 0.81 | -0.45 | -0.01 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 19.31% | 17.09% | 17.74% | 29.79% | 32.10% | -13.33% | 1,000.00% |
0.11 | -0.97 | -0.54 | -0.18 | 0.39 | 1.17 | 1.31 | 3.56 | 2.72 | 0.56 | -0.39 | -0.11 | |
EPS in Rs | 0.36 | -3.16 | -1.76 | -0.59 | 1.27 | 3.81 | 4.27 | 11.60 | 8.86 | 1.82 | -1.27 | -0.36 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 5% |
3 Years: | -14% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | % |
3 Years: | % |
TTM: | 72% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 25% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 11% |
3 Years: | 0% |
Last Year: | -1% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 |
Reserves | 0.70 | -0.28 | -0.82 | -1.05 | -0.66 | 0.52 | 1.83 | 5.39 | 8.10 | 8.66 | 8.27 | 7.91 |
6.46 | 6.70 | 8.17 | 8.02 | 8.01 | 7.69 | 9.73 | 10.86 | 11.60 | 13.63 | 15.54 | 15.02 | |
3.00 | 2.74 | 1.27 | 1.58 | 1.48 | 3.59 | 3.18 | 7.55 | 6.86 | 5.65 | 4.49 | 6.19 | |
Total Liabilities | 13.23 | 12.23 | 11.69 | 11.62 | 11.90 | 14.87 | 17.81 | 26.87 | 29.63 | 31.01 | 31.37 | 32.19 |
10.41 | 10.09 | 9.98 | 9.71 | 9.62 | 10.69 | 12.31 | 20.39 | 22.38 | 24.51 | 25.08 | 25.83 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 1.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
2.82 | 2.14 | 1.71 | 1.91 | 2.28 | 3.94 | 4.16 | 6.48 | 7.25 | 6.50 | 6.29 | 6.36 | |
Total Assets | 13.23 | 12.23 | 11.69 | 11.62 | 11.90 | 14.87 | 17.81 | 26.87 | 29.63 | 31.01 | 31.37 | 32.19 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.09 | -0.16 | -1.50 | -0.13 | 0.56 | 2.56 | 1.28 | 6.49 | 2.90 | 0.27 | -0.03 | 2.65 | |
0.28 | 0.06 | -0.08 | 0.32 | -0.38 | -1.71 | -3.20 | -7.51 | -3.05 | -3.29 | -1.87 | -2.14 | |
-0.04 | -0.13 | 1.57 | -0.16 | -0.16 | -0.45 | 1.70 | 1.13 | 0.74 | 2.04 | 1.90 | -0.52 | |
Net Cash Flow | 0.15 | -0.23 | -0.02 | 0.03 | 0.01 | 0.40 | -0.22 | 0.11 | 0.59 | -0.98 | 0.01 | -0.01 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 12.51 | 26.89 | 31.37 | 24.81 | 27.13 | 55.08 | 39.86 | 67.86 | 41.60 | 47.24 | 47.10 | 55.07 |
Inventory Days | 126.69 | 44.60 | 136.35 | 580.41 | 16.18 | 231.23 | 217.06 | 165.17 | 80.99 | 200.09 | 386.19 | 167.61 |
Days Payable | 156.86 | 126.75 | 159.43 | 741.97 | 43.60 | 605.79 | 366.21 | 695.35 | 159.36 | 200.78 | 111.85 | 201.64 |
Cash Conversion Cycle | -17.66 | -55.26 | 8.29 | -136.75 | -0.29 | -319.48 | -109.29 | -462.31 | -36.77 | 46.55 | 321.44 | 21.04 |
Working Capital Days | -6.82 | -25.91 | 26.38 | 22.44 | 20.00 | -4.56 | 8.77 | -32.10 | -0.60 | 25.10 | 49.98 | 12.75 |
ROCE % | 3.04% | -6.90% | -3.21% | -2.44% | 5.28% | 13.73% | 13.89% | 28.39% | 16.35% | 5.82% | 1.00% | 2.99% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Publication of the financial Result for the quarter and year ended March, 31, 2025
-
Integrated Filing (Financial)
2d - Approved audited financial results for FY ended 31 Mar 2025 with unmodified audit opinion.
- Audited Financial Results (Standalone) For The Quarter And Financial Year Ended March 31, 2025 2d
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May, 2025
2d - Approved audited financial results for FY ended March 31, 2025, with unmodified audit opinion.
-
Update on board meeting
8 May - Board meeting on May 23 to approve audited Q4 and annual results for FY25; trading window update.
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2005
from bse
-
Financial Year 2004
from bse
-
Financial Year 2003
from bse
About[1]
The company is into manufacturing chemical dyes and specialty intermediates for leading agrochemical and pharmaceutical companies in India.